3 recruiting, 2 completed, 1 terminated. 6 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 3, Completed 2, Terminated 1 |
| Phase 2 | 5 | Recruiting 3, Completed 1, Terminated 1 |
Follow Visudyne: new trials by email Literature Review of Visudyne trials Research Report on Visudyne
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System Photodynamic Therapy (PDT), Verteporfin Injection - Prostate Cancer | Phase 1 / Phase 2 | Recruiting | SpectraCure AB | 43 | 2025-01-06 | 2026-05-01 |
| Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction Biospecimen Collection, Computed Tomography, Endobronchial Ultrasound Bronchoscopy - Malignant Solid Neoplasm | Phase 1 / Phase 2 | Recruiting | Roswell Park Cancer Institute | 42 | 2024-10-01 | 2026-04-06 |
| Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma Verteporfin - Glioblastoma, Recurrent Glioblastoma | Phase 1 / Phase 2 | Terminated | Emory University | 9 | 2021-01-15 | 2026-10-28 |
| Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System Verteporfin, SpectraCure P18 System - Recurrent Prostate Cancer | Phase 1 / Phase 2 | Recruiting | SpectraCure AB | 66 | 2017-03-21 | 2026-05-01 |
| Photodynamic Therapy for the Treatment of Vertebral Metastases Visudyne - Vertebral Metastases | Phase 1 | Completed | Sunnybrook Health Sciences Centre | 30 | 2011-06-01 | 2018-02-15 |
| Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Verteporfin, ranibizumab - Chronic Central Serous Chorioretinopathy | Phase 1 / Phase 2 | Completed | Jang Won Heo | 34 | 2009-07-01 | 2013-05-27 |
Prostatic Neoplasms (2) · Glioblastoma (1)
SpectraCure AB (2) · Emory University (1) · Jang Won Heo (1) · Roswell Park Cancer Institute (1) · Sunnybrook Health Sciences Centre (1)
United States (4) · Canada (2) · Germany (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Jang Won Heo, Professor (1) · Jonathan Fainberg, MD, MPH (1) · Nathaniel Ivanick (1) · William L Read, MD (1)
P30CA138292 (1), R01CA283547 (1)